The Year in Molecular Imaging

JACC: Cardiovascular Imaging

Volumn 2, Issue 1, 2009, Pages 97-113

  Osborn, Eric A ^a   Jaffer, Farouc A ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Center for Molecular Imaging Research   (United States)

Author keywords

atherosclerosis; heart failure; molecular imaging; myocardial infarction; thrombosis

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 13; CASPASE 3 INHIBITOR; CASPASE 8 INHIBITOR; CASPASE 9 INHIBITOR; DALTEPARIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EP 2104R; FLUORINE; FLUORODEOXYGLUCOSE F 18; FUMAGILLIN; GADOLINIUM; GADOTERIC ACID; GALLIUM 68; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDIUM 111; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; IODINE 123; IRON OXIDE; LOSARTAN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE DERIVATIVE; TECHNETIUM 99M; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ACUTE CORONARY SYNDROME; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERY THROMBOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE DEVELOPMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DRUG SAFETY; DRUG SPECIFICITY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ENZYME INHIBITION; FIBRINOLYSIS; GENE EXPRESSION; HEART INFARCTION; HUMAN; INFLAMMATION; LIMB ISCHEMIA; MOLECULAR IMAGING; MONOTHERAPY; MYOCARDIAL HIBERNATION; NEAR INFRARED SPECTROSCOPY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; STROKE; VASCULAR ENDOTHELIUM;

AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; FEMALE; HEART FUNCTION TESTS; HUMANS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 58149513331     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.11.001     Document Type: Review

References (40)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Hartung D., Petrov A., Haider N., et al. Radiolabeled monocyte chemotactic protein 1 for the detection of inflammation in experimental atherosclerosis. J Nucl Med 48 (2007) 1816-1821
3. Aikawa E., Nahrendorf M., Figueiredo J.L., et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116 (2007) 2841-2850
4. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003) 1664-1672
5. Sarai M., Hartung D., Petrov A., et al. Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging. J Am Coll Cardiol 50 (2007) 2305-2312
6. Kietselaer B.L., Reutelingsperger C.P., Heidendal G.A., et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350 (2004) 1472-1473
7. Kircher M.F., Grimm J., Swirski F.K., et al. Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 117 (2008) 388-395
8. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
9. McAteer M.A., Schneider J.E., Ali Z.A., et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 28 (2008) 77-83
10. Kelly K.A., Allport J.R., Tsourkas A., Shinde-Patil V.R., Josephson L., and Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 96 (2005) 327-336
11. Nahrendorf M., Jaffer F.A., Kelly K.A., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114 (2006) 1504-1511
12. Morris J.B., Olzinski A.R., Bernard R.E., et al. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol 28 (2008) 265-271
13. Lancelot E., Amirbekian V., Brigger I., et al. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol 28 (2008) 425-432
14. Deguchi J.O., Aikawa E., Libby P., et al. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112 (2005) 2708-2715
15. Aziz K., Berger K., Claycombe K., Huang R., Patel R., and Abela G.S. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation 117 (2008) 2061-2070
16. Briley-Saebo K.C., Shaw P.X., Mulder W.J., et al. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation 117 (2008) 3206-3215
17. von zur Muhlen C., von Elverfeldt D., Moeller J.A., et al. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 118 (2008) 258-267
18. Korosoglou G., Weiss R.G., Kedziorek D.A., et al. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol 52 (2008) 483-491
19. Amirbekian V., Lipinski M.J., Briley-Saebo K.C., et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A 104 (2007) 961-966
20. Nahrendorf M., Aikawa E., Figueiredo J.L., et al. Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction. Eur Heart J 29 (2008) 445-454
21. Nahrendorf M., Sosnovik D., Chen J.W., et al. Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation 117 (2008) 1153-1160
22. Rodriguez-Porcel M., Cai W., Gheysens O., et al. Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med 49 (2008) 667-673
23. Verjans J.W.H., Lovhaug D., Narula N., et al. Noninvasive imaging of angiotensin receptors after myocardial infarction. J Am Coll Cardiol Img 1 (2008) 354-362
24. Behm C.Z., Kaufmann B.A., Carr C., et al. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 117 (2008) 2902-2911
25. Helm P.A., Caravan P., French B.A., et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology 247 (2008) 788-796
26. Flogel U., Ding Z., Hardung H., et al. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118 (2008) 140-148
27. Johnson L.L., Schofield L., Donahay T., Bouchard M., Poppas A., and Haubner R. Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. J Am Coll Cardiol Img 1 (2008) 500-510
28. Makowski M.R., Ebersberger U., Nekolla S., and Schwaiger M. In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction. Eur Heart J 29 (2008) 2201
29. Li Z., Wu J.C., Sheikh A.Y., et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116 (2007) I46-I54
30. Rodriguez-Porcel M., Brinton T.J., Chen I.Y., et al. Reporter gene imaging following percutaneous delivery in swine moving toward clinical applications. J Am Coll Cardiol 51 (2008) 595-597
31. Doyle B., Kemp B.J., Chareonthaitawee P., et al. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med 48 (2007) 1708-1714
32. Nahrendorf M., Zhang H., Hembrador S., et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117 (2008) 379-387
33. Jaffer F.A., Nahrendorf M., Sosnovik D., Kelly K.A., Aikawa E., and Weissleder R. Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging 5 (2006) 85-92
34. Judenhofer M.S., Wehrl H.F., Newport D.F., et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14 (2008) 459-465
35. Winter P.M., Caruthers S.D., Zhang H., Williams T.A., Wickline S.A., and Lanza G.M. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. J Am Coll Cardiol Img 1 (2008) 624-634
36. Tahara N., Kai H., Nakaura H., et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J 28 (2007) 2243-2248
37. Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 (2006) 1825-1831
38. Rudd J.H., Myers K.S., Bansilal S., et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 49 (2008) 871-878
39. Tang T.Y., Howarth S.P., Miller S.R., et al. Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis. Stroke 39 (2008) 2144-2147
40. Spuentrup E., Botnar R.M., Wiethoff A.J., et al. MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 18 (2008) 1995-2005